Value proposition

40% of dementia is not diagnosed. We partner with healthcare providers and payers to change that.

SPARK Neuro's mission is to make brain health assessments a standard part of care. Targeting the 40% of dementia cases that are undiagnosed, SPARK provides a comprehensive assessment service for healthcare payers and providers, propelled by its AI-enabled and FDA-cleared EEG brain scan.

SPARK Neuro has a history of collaborating with prestigious institutions like the Mayo Clinic and Johns Hopkins Medicine and has earned funding from the Department of Defense and the National Institutes of Health. SPARK Neuro's flagship innovation delivers an objective, non-invasive, and scalable approach to brain health assessment.

Biomarker Development, Alzheimer's Disease, Dementia, and Artificial Intelligence